The role of CMV in steroid-resistant ulcerative colitis: A systematic review

Journal of Crohn's and Colitis

Volumn 3, Issue 3, 2009, Pages 141-148

  Ayre, Karyn ^a   Warren, Bryan F ^b   Jeffery, Katie ^b   Travis, Simon P L ^b  

^a QUEEN MARGARET HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Cytomegalovirus; Review; Steroid resistance; Therapy; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; GANCICLOVIR; IMMUNOGLOBULIN G; IMMUNOMODULATING AGENT; INFLIXIMAB; MESALAZINE; PREDNISOLONE; STEROID;

CHEMOPROPHYLAXIS; COLONOSCOPY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFECT; DRUG TOLERABILITY; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; INTESTINE BIOPSY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SEROLOGY; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; VIREMIA; VIRUS DETECTION; VIRUS REACTIVATION;

EID: 67651102724     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2009.03.002     Document Type: Review

References (40)

1. Travis S.P.L., Stange E.F., Lémann M., et al. European evidence-based consensus on the management of ulcerative colitis: current management for the European Crohn's and Colitis Organisation (ECCO). J Crohns Colitis 2 1 (2008) 1-98
2. Creed T.J., and Probert C.S. Review article: steroid resistance in inflammatory bowel disease-mechanisms and therapeutic strategies. Aliment Pharmacol Ther 25 2 (2007) 111-122
3. Cottone M., Pietrosi G., Martorana G., et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 96 3 (2001) 773-775
4. Takahashi Y., and Tange T. Prevalence of cytomegalovirus infection in inflammatory bowel disease patients. Dis Colon Rectum 47 (2004) 722-726
5. Kambham N., Vij R., Cartwright C.A., and Longacre T. Cytomegalovirus infection in steroid-refractory ulcerative colitis. Am J Surg Pathol 28 (2004) 365-373
6. Banerjee D., Deb R., Dar L., et al. High frequency of parasitic and viral stool pathogens in patients with active ulcerative colitis: report from a tropical country. Scand J Gastroenterol 28 (2008) 1-7
7. Polić B., Hengel H., Krmpotić A., et al. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 188 6 (1998) 1047-1054
8. Bennekov T., Spector D., and Langhoff E. Induction of immunity against human cytomegalovirus. Mt Sinai J Med 71 2 (2004) 86-93
9. Yoshikawa T. Significance of human herpes viruses to transplant recipients. Curr Opin Infect Dis 16 6 (2003) 601-606
10. Ho M. The history of cytomegalovirus and its diseases. Med Microbiol Immunol 197 2 (2008) 65-73
11. JE Gallant, RD Moore, DD Richman, J Keruly, RE Chaisson. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 1992; 166 (6): 1223-1, as cited in M Ho. Med Microbiol Immunol 2008; 197 (2) 65-7.
12. RH Rubin. Infections in the organ transplant recipient. In: RH Rubin, LS Young, eds. Clinical approach to infection in the compromised host, 4th edn. Kluwer Academic/Plenum, New York: 2002, 573-6, as cited by BH Tan. CMV prophylaxis-to do or not to do, that is the question. Nephrol Dial Transplant 2006; 21: 1757-61.
13. Kandiel A., and Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol 101 (2006) 2857-2865
14. JF Rahier, S Ben-Horin, Y Chowers, et al. on behalf of the European Crohn's and Colitis Organisation (ECCO). European evidence-based consensus on the prevention, detection and management of opportunistic infections in IBD. J Crohn's Colitis (in press).
15. V Knez, JA Stewart, DW Ziegler. Cytomegalovirus specific IgM and IgG response in humans studied by radioimmunoassay. J Immunol 1976; 117: 2006-1 as cited in P Pfau, ML Kochman, EE Furth, GR Lichtenstein. Cytomegalovirus colitis complicating ulcerative colitis in the steroid-naive patient. Am J Gastroenterol 2001; 96 (3): 895-9.
16. Berkelhammer C. Cytomegalovirus negative blood transfusions in CMV-negative inflammatory bowel disease patients. Inflamm Bowel Dis 13 9 (2007) 1184
17. Pfau P., Kochman M.L., Furth E.E., and Lichtenstein G.R. Cytomegalovirus colitis complicating ulcerative colitis in the steroid-naive patient. Am J Gastroenterol 96 3 (2001) 895-899
18. Yoda Y, Hanaoka R, Ide H, Isozaki T, Matsunawa M, Yajima N, Shiozawa F, Miwa Y, Negishi M, Kasama T. Clinical evaluation of patients with inflammatory connective tissue diseases complicated by cytomegalovirus antigenemia. Mod Rheumatol 2006; 16 (3): 137-4, as cited in Yoshino T, Nakase H, Ueno S, Uza N, Inoue S, Mikami S, Matsuura M, Ohmori K, Sakurai T, Nagayama S, Hasegawa S, Sakai Y, Chiba T. Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies. Inflamm Bowel Dis 2007; 13 (12): 1516-2.
19. Stange E.F., Travis S.P.L., Vermeire S., et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. European Crohn's and Colitis Organisation (ECCO). J Crohns Colitis 2 1 (2008) 1-21
20. Roskell D.E., Hyde G.M., Campbell A.P., Jewell D.P., and Gray W. HIV associated cytomegalovirus colitis as a mimic of inflammatory bowel disease. Gut 37 1 (1995) 148-150
21. ET Tatum, PC Sun, DL Cohn. Cytomegalovirus vasculitis and colon perforation in a patient with the acquired immunodeficiency syndrome. Pathology 1989; 21(4): 235-8 as cited in Roskell DE, Hyde GM, Campbell AP, Jewell DP, Gray W. HIV associated cytomegalovirus colitis as a mimic of inflammatory bowel disease. Gut 1995; 37 (1):148-5.
22. Hunt N.C.A., Jewell D.P., Mortensen N.J.Mc.C., and Warren B.F. Cytomegalovirus complicating ulcerative colitis. CPD Bulletin in Cellular Pathology (1999), Rila, London 72-73
23. L Beaugerie, C Cywiner-Golenzer, L Monfort, et al. Definition and diagnosis of cytomegalovirus colitis in patients infected by human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:423-9, as cited in A Kandiel, B Lashner. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol 2006;101:2857-65.
24. Lavagna A., Bergallo M., Daperno M., et al. The hazardous burden of Herpesviridae in inflammatory bowel disease: the case of refractory severe ulcerative colitis. Dig Liver Dis 38 12 (2006) 887-893
25. Gerna G., and Lilleri D. Monitoring transplant patients for human cytomegalovirus: diagnostic update. Herpes 13 1 (2006) 3
26. Yoshino T., Nakase H., Ueno S., et al. Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies. Inflamm Bowel Dis 13 12 (2007) 1516-1521
27. HS Kaufman, AC Kahn, C Iacobuzio-Donahue, MA Talamini, KD Lillemoe, SR Hamilton. Cytomegaloviral enterocolitis: clinical associations and outcome. Dis Colon Rectum 1999; 42: 24-30, as cited in Y Wada, T Matsui, H Matake, et al. Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment. Dis Colon Rectum 2003; 46 (10 Suppl): S59-6.
28. Maconi G., Colombo E., Zerbi P., et al. Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection. Dig Liver Dis 37 (2005) 418-423
29. T Berk, SJ Gordon, HY Choi, HS Cooper. Cytomegalovirus infection of the colon: a possible role in exacerbations of inflammatory bowel disease. Am J Gastroenterol 1985; 80 (5): 355-6 as cited in Y Takahashi, T Tange. Prevalence of cytomegalovirus infection in inflammatory bowel disease patients. Dis Col Rectum 2004;47:722-2.
30. Kuwabara A., Okamoto H., Suda T., Ajioka Y., and Hatakeyama K. Clinicopathologic characteristics of clinically relevant cytomegalovirus infection in inflammatory bowel disease. J Gastroenterol 42 10 (2007) 823-829
31. Kojima T., Watanabe T., Hata K., Shinozaki M., Yokoyama T., and Nagawa H. Cytomegalovirus infection in ulcerative colitis. Scand J Gastroenterol 41 6 (2006) 706-711
32. Domènech E., Vega R., Ojanguren I., et al. Cytomeaglovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis 14 10 (2008) 1373-1379
33. Criscuoli V., Casa A., Orlando A., et al. Severe acute colitis associated with CMV: a prevalence study. Dig Liver Dis 36 12 (2004) 818-820
34. D Ovidio V., Vernia P., Gentile G., et al. Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy. J Clin Virol 43 2 (2008) 180-183 [Electronic publication ahead of print]
35. Osaki R., Andoh A., Tsujikawa T., et al. Acute cytomegalovirus infection superimposed on corticosteroid-naive ulcerative colitis. Intern Med 47 14 (2008) 1341-1344
36. Babyatsky M.W., Keroak M.D., Blake M.A., Rosenberg E.S., and Mino-Kenudson M. Case records of the Massachusetts General Hospital Case 35-2007. A 30-year old man with inflammatory bowel disease and recent onset of fever and bloody diarrhoea. N Engl J Med 357 (2007) 2068-2076
37. Wada Y., Matsui T., Matake H., et al. Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment. Dis Colon Rectum 46 10 Suppl (2003) S59-65
38. Roblin X., and Bonaz B. Is cytomegalovirus really a cause of resistance to steroids in ulcerative colitis?. Dis Colon Rectum 48 1 (2005) 174
39. FS Vogel. Enhanced susceptibility of proliferating endothelium to salivary gland virus under naturally occurring and experimental conditions Am J Path 1958; 34: 1064-7 as cited in IA Eyre-Brook, S Dundas. Incidence and clinical significance of colonic cytomegalovirus infection in idiopathic inflammatory bowel disease requiring colectomy. Gut 1986; 27 (12): 1419-25.
40. Eyre-Brook I.A., and Dundas S. Incidence and clinical significance of colonic cytomegalovirus infection in idiopathic inflammatory bowel disease requiring colectomy. Gut 27 12 (1986) 1419-1425